Fig. 5From: Apatinib preferentially inhibits PC9 gefitinib-resistant cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathwayPathway enrichment for PC9GR cells after treatment with apatinib. a Enriched KEGG pathways. Cell cycle and DNA replication were mostly enriched by p value. b Gene ontology (GO) analysis of enriched biological processes. The two most significant ones are cell cycle and mitotic cell cycle process. network mapsBack to article page